| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 02:05:42 UTC |
|---|
| Update Date | 2021-09-26 22:59:03 UTC |
|---|
| HMDB ID | HMDB0248664 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine |
|---|
| Description | This compound has been identified in human blood as reported by (PMID: 31557052 ). N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-n4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | COC1=CC(=CC=C1NC1=NC(NC2=CC=CC=C2S(=O)(=O)C(C)C)=NC=N1)N1CCC(CC1)N1CCN(C)CC1 InChI=1S/C29H40N8O3S/c1-21(2)41(38,39)27-8-6-5-7-25(27)33-29-31-20-30-28(34-29)32-24-10-9-23(19-26(24)40-4)36-13-11-22(12-14-36)37-17-15-35(3)16-18-37/h5-10,19-22H,11-18H2,1-4H3,(H2,30,31,32,33,34) |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C29H40N8O3S |
|---|
| Average Molecular Weight | 580.75 |
|---|
| Monoisotopic Molecular Weight | 580.294408354 |
|---|
| IUPAC Name | N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}-N4-[2-(propane-2-sulfonyl)phenyl]-1,3,5-triazine-2,4-diamine |
|---|
| Traditional Name | N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}-N4-[2-(propane-2-sulfonyl)phenyl]-1,3,5-triazine-2,4-diamine |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | COC1=CC(=CC=C1NC1=NC(NC2=CC=CC=C2S(=O)(=O)C(C)C)=NC=N1)N1CCC(CC1)N1CCN(C)CC1 |
|---|
| InChI Identifier | InChI=1S/C29H40N8O3S/c1-21(2)41(38,39)27-8-6-5-7-25(27)33-29-31-20-30-28(34-29)32-24-10-9-23(19-26(24)40-4)36-13-11-22(12-14-36)37-17-15-35(3)16-18-37/h5-10,19-22H,11-18H2,1-4H3,(H2,30,31,32,33,34) |
|---|
| InChI Key | MGGBYMDAPCCKCT-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Classification | Not classified |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 10.4625 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.92 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1513.4 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 128.2 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 185.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 141.4 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 73.2 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 448.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 528.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 145.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 904.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 285.7 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 727.6 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 244.2 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 333.5 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 159.1 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 384.4 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 17.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,1TMS,isomer #1 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1N(C1=NC=NC(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1)[Si](C)(C)C | 4742.6 | Semi standard non polar | 33892256 | | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,1TMS,isomer #1 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1N(C1=NC=NC(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1)[Si](C)(C)C | 4464.8 | Standard non polar | 33892256 | | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,1TMS,isomer #1 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1N(C1=NC=NC(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1)[Si](C)(C)C | 7000.6 | Standard polar | 33892256 | | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,1TMS,isomer #2 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1NC1=NC=NC(N(C2=CC=CC=C2S(=O)(=O)C(C)C)[Si](C)(C)C)=N1 | 4713.0 | Semi standard non polar | 33892256 | | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,1TMS,isomer #2 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1NC1=NC=NC(N(C2=CC=CC=C2S(=O)(=O)C(C)C)[Si](C)(C)C)=N1 | 4554.7 | Standard non polar | 33892256 | | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,1TMS,isomer #2 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1NC1=NC=NC(N(C2=CC=CC=C2S(=O)(=O)C(C)C)[Si](C)(C)C)=N1 | 6927.1 | Standard polar | 33892256 | | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,2TMS,isomer #1 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1N(C1=NC=NC(N(C2=CC=CC=C2S(=O)(=O)C(C)C)[Si](C)(C)C)=N1)[Si](C)(C)C | 4596.2 | Semi standard non polar | 33892256 | | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,2TMS,isomer #1 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1N(C1=NC=NC(N(C2=CC=CC=C2S(=O)(=O)C(C)C)[Si](C)(C)C)=N1)[Si](C)(C)C | 4624.2 | Standard non polar | 33892256 | | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,2TMS,isomer #1 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1N(C1=NC=NC(N(C2=CC=CC=C2S(=O)(=O)C(C)C)[Si](C)(C)C)=N1)[Si](C)(C)C | 6341.9 | Standard polar | 33892256 | | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,1TBDMS,isomer #1 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1N(C1=NC=NC(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1)[Si](C)(C)C(C)(C)C | 4923.2 | Semi standard non polar | 33892256 | | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,1TBDMS,isomer #1 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1N(C1=NC=NC(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1)[Si](C)(C)C(C)(C)C | 4695.3 | Standard non polar | 33892256 | | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,1TBDMS,isomer #1 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1N(C1=NC=NC(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1)[Si](C)(C)C(C)(C)C | 7000.4 | Standard polar | 33892256 | | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,1TBDMS,isomer #2 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1NC1=NC=NC(N(C2=CC=CC=C2S(=O)(=O)C(C)C)[Si](C)(C)C(C)(C)C)=N1 | 4896.4 | Semi standard non polar | 33892256 | | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,1TBDMS,isomer #2 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1NC1=NC=NC(N(C2=CC=CC=C2S(=O)(=O)C(C)C)[Si](C)(C)C(C)(C)C)=N1 | 4779.4 | Standard non polar | 33892256 | | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,1TBDMS,isomer #2 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1NC1=NC=NC(N(C2=CC=CC=C2S(=O)(=O)C(C)C)[Si](C)(C)C(C)(C)C)=N1 | 6927.0 | Standard polar | 33892256 | | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,2TBDMS,isomer #1 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1N(C1=NC=NC(N(C2=CC=CC=C2S(=O)(=O)C(C)C)[Si](C)(C)C(C)(C)C)=N1)[Si](C)(C)C(C)(C)C | 4956.4 | Semi standard non polar | 33892256 | | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,2TBDMS,isomer #1 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1N(C1=NC=NC(N(C2=CC=CC=C2S(=O)(=O)C(C)C)[Si](C)(C)C(C)(C)C)=N1)[Si](C)(C)C(C)(C)C | 5081.5 | Standard non polar | 33892256 | | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,2TBDMS,isomer #1 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1N(C1=NC=NC(N(C2=CC=CC=C2S(=O)(=O)C(C)C)[Si](C)(C)C(C)(C)C)=N1)[Si](C)(C)C(C)(C)C | 6281.8 | Standard polar | 33892256 |
|
|---|
| MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 10V, Positive-QTOF | splash10-001i-0001090000-e646198bd00ac479b57f | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 20V, Positive-QTOF | splash10-001j-1226490000-df7887775a11ee62e49e | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 40V, Positive-QTOF | splash10-0006-3594430000-5661a806008185f36256 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 10V, Negative-QTOF | splash10-004i-0123090000-8fc85ed215c6b9fc618c | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 20V, Negative-QTOF | splash10-004v-3495070000-73550433df5ce1a2cb55 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 40V, Negative-QTOF | splash10-0006-5595840000-58fa1076a1befaa411e0 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 10V, Positive-QTOF | splash10-001i-0000090000-4f22b53ae216b3738512 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 20V, Positive-QTOF | splash10-001i-0000190000-624cc852dc9c4bfbacf5 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 40V, Positive-QTOF | splash10-00xv-6723690000-9c6a1abd74e710482fc8 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 10V, Negative-QTOF | splash10-004i-0000090000-d6312a67f31d57607c4c | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 20V, Negative-QTOF | splash10-004i-0000290000-05ec049b3d0a373d13d4 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 40V, Negative-QTOF | splash10-004i-5121190000-9a7973a44fea734c2403 | 2021-10-12 | Wishart Lab | View Spectrum |
|
|---|